⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7827555 | 0.79 | — | — | |
| SCHEMBL79539 | 0.79 | — | — | |
| SCHEMBL30295390 | 0.79 | ALOX5 (0.47) | — | |
| SCHEMBL27818681 | 0.76 | ALOX5 (0.39) | — | |
| SCHEMBL1310355 | 0.75 | — | — | |
| SCHEMBL5101400 | 0.75 | — | — | |
| SCHEMBL5002209 | 0.75 | — | — | |
| SCHEMBL142218 | 0.75 | — | — | |
| SCHEMBL18827337 | 0.75 | ALOX5 (0.44) | — | |
| SCHEMBL1309777 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104374858-B | A kind of detection method of sufentanil citrate synthesis material and impurity | 宜昌人福药业有限责任公司 | 2016-06-29 | — | — | CN | claimed |
| CN-110627610-B | Method for synthesizing alkyne by catalyzing asymmetric cross coupling | 南方科技大学 | 2022-07-05 | — | — | CN | disclosed |
| CN-104066732-B | Novel antiviral Pyrrolopyridine derivatives and preparation method thereof | KOREA CHEMICAL RESEARCH INSTITUTE (KR) | 2016-04-13 | — | — | CN | disclosed |
| CN-105209428-A | Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders | ACUCELA INC | 2015-12-30 | — | — | CN | disclosed |
| CN-104487496-A | Materials coated with calixarenes | UNIV LIBRE DE BRUXELLES ULB | 2015-04-01 | — | — | CN | disclosed |
| CN-104066732-A | Novel antiviral pyrrolopyridine derivative and a production method for same | KOREA RES INST CHEM TECH | 2014-09-24 | — | — | CN | disclosed |
| CN-101939313-B | 3,8-diaminotetrahydroquinoline derivative | ZERIA PHARM CO LTD | 2013-05-22 | — | — | CN | disclosed |
| US-8053378-B2 | Modified phenolic resin, epoxy resin composition containing the same, and prepreg containing the composition | MITSUI CHEMICALS, INC. (JP) | 2011-11-08 | — | — | US | disclosed |
| CN-101939313-A | 3,8-diamino tetrahydroquinoline derivative | ZERIA PHARM CO LTD | 2011-01-05 | — | — | CN | disclosed |
| US-20090137822-A1 | Process for preparing 3-substituted thiophene | UBE INDUSTRIES, LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-1276725-A2 | 5-SUBSTITUTED TETRALONES AS INHIBITORS OF RAS FARNESYL TRANSFERASE | WARNER-LAMBERT COMPANY (US) | 2003-01-22 | — | — | EP | disclosed |
| WO-2001079180-A2 | 5-SUBSTITUTED TETRALONES AS INHIBITORS OF RAS FARNESYL TRANSFERASE | WARNER-LAMBERT COMPANY (US) | 2001-10-25 | — | — | WO | disclosed |
| EP-0661271-B1 | AZEPINE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS SIGMA-RECEPTOR LIGANDS | ASAHI CHEMICAL IND (JP) | 2000-04-26 | — | — | EP | disclosed |
| EP-0574313-B1 | 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders | ADIR (FR) | 1999-10-06 | — | — | EP | disclosed |
| CN-1219169-A | Substituted benzylamines and their use for the treatment of depression | AKZO NOBEL NV (NL) | 1999-06-09 | — | — | CN | disclosed |
| US-5658923-A | USED IN TREATING DISEASES RELATED TO SIGMA-RECEPTOR, SUCH AS SCHIZOPHRENIA | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1997-08-19 | — | — | US | disclosed |
| US-5464834-A | Antidepressants, central nervous system | ADIR ET COMPAGNIE (FR) | 1995-11-07 | — | — | US | disclosed |
| EP-0661271-A1 | AZEPINE DERIVATIVE, PRODUCTION THEREOF, AND USE THEREOF | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1995-07-05 | — | — | EP | disclosed |
| EP-0574313-A1 | 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders | ADIR ET COMPAGNIE (FR) | 1993-12-15 | — | — | EP | disclosed |
| US-3998956-A | Pharmaceutical compositions containing a 1-(thienyl-methyl)-2-anilino-2-imidazoline and method of use | BOEHRINGER INGELHEIM GMBH (DT) | 1976-12-21 | — | — | US | disclosed |